注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Michael F. Burgess | 60 | 2021 | Interim Chief Medical Officer & Executive Director |
Robert J. Gould | 69 | 2019 | Independent Director |
Jerel C. Davis | 47 | 2015 | Independent Chairman of the Board & Lead Independent Director |
Alan Melcher | - | - | Member of the Scientific Advisory Board |
Bernard A. Fox | 70 | - | Member of the Scientific Advisory Board |
Jeffrey S. Weber | - | 2023 | Member of the Scientific Advisory Board |
Eric Tran | - | - | Member of the Scientific Advisory Board |
Rishi Gupta | 47 | 2016 | Independent Director |
Thomas W. Dubensky | 66 | - | Member of the Scientific Advisory Board |
Malcolm K. Brenner | 72 | - | Member of Scientific Advisory Board |
James J. Mule | 71 | - | Member of the Scientific Advisory Board |
Nicholas Restifo | 62 | - | Member of the Scientific Advisory Board |
Adrian Hill | - | - | Member of the Scientific Advisory Board |
William D. Waddill | 67 | 2024 | Independent Director |
Robert A. Seder | - | - | Member of the Scientific Advisory Board |
Kanya Rajangam | 50 | 2021 | Independent Director |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核